Breaking News Instant updates and real-time market news.
2018-03-23 04:55:00
NERV
Minerva
$6.50
-0.2 (-2.99%)
04:55
03/23/18
03/23
04:55
03/23/18
04:55
Minerva management to meet with Jefferies
Meetings to be held in New York on March 22-23 hosted by Jefferies.
23
Mar
NERVMinerva
$6.50
-0.2 (-2.99%)
09/01/17
SBSH
09/01/17 INITIATIONTarget $11 SBSH Buy
Minerva Neurosciences initiated with a Buy at Citi
Citi analyst Joel Beatty started Minerva Neurosciences with a Buy rating and $11 price target. The Phase 3 trial for lead agent MIN-101 in negative symptoms of schizophrenia is well positioned for success, Beatty tells investors in a research note. He sees negative symptoms of schizophrenia as an attractive market opportunity because there are no approved drugs for the indication.
09/01/17
09/01/17 INITIATION
On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. DowDuPont (DWDP) initiated with an Outperform at Bernstein. 2. Minerva (NERV) Neurosciences initiated with a Buy at Citi. 3. VMware (VMW) resumed with a Sector Weight at KeyBanc. 4. Provident Financial (PFS) initiated with a Neutral at DA Davidson. 5. Maximus (MMS) initiated with a Neutral at Baird. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.